ArticleJMIR infodemiology2026
Identifying Public Response Topics to the Centers for Disease Control and Prevention's COVID-19 Communications on Social Media: Infoveillance Study Using Large Language Model-Based Rephrasing.
Article in JMIR infodemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Public health agencies increasingly use social media platforms such as Twitter (subsequently rebranded X, X Corp) to monitor public responses to official health communications and support timely decision-making during health crises. Public replies to communications from official agencies provide valuable insights into population-level discourse and engagement with health policies. However, analyzing large-scale short-text responses remains challenging because social media replies are often brief, informal, ambiguous, and linguistically fragmented. Topic modeling offers a scalable approach for identifying thematic patterns in such data, but its performance is often limited when applied to social media short texts. Recent advances in large language models (LLMs) provide new opportunities to improve text normalization before topic modeling, but their value and limitations for public health infoveillance remain underexplored. Objective: This study develops and evaluates TM-Rephrase, a model-agnostic LLM-based rephrasing framework designed to improve the performance of topic models for short public health social media texts while ensuring rephrasing preserves the original semantic meaning, stance or intent, and tone. Methods: We analyzed 25,027 public replies to official Centers for Disease Control and Prevention tweets on Twitter collected between May 2020 and November 2022. TM-Rephrase transformed informal and noisy short texts into more standardized expressions using 2 prompt-guided schemes: general rephrasing and colloquial-to-formal rephrasing. Original and rephrased texts were analyzed using multiple topic models, with rephrasing generated by Gemini 2.5 Flash, GPT‑4o mini, and Mistral-7B-Instruct. Topic quality was evaluated using coherence, uniqueness, redundancy, and diversity. We also conducted an expert semantic-fidelity validation study in which 4 expert raters evaluated whether rephrased texts preserved the original meaning, stance or intent, and tone. Results: TM-Rephrase generally improved topic quality across models, rephrasing schemes, and LLM backbones. For latent Dirichlet allocation, Conclusions: TM-Rephrase can enhance the coherence, distinctiveness, and interpretability of topic modeling outputs for short, noisy public health social media data. However, it is a text-normalization preprocessing strategy for topic enhancement rather than a fully neutral replacement for original public discourse.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.